<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03171298</url>
  </required_header>
  <id_info>
    <org_study_id>transanal surgical approach</org_study_id>
    <nct_id>NCT03171298</nct_id>
  </id_info>
  <brief_title>Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision</brief_title>
  <official_title>Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rectal cancer is one of the frequent malignant neoplasms ,Total mesorectal excision (TME) has
      become the gold standard treatment for middle and lower rectal cancers. Laparoscopic TME
      still be difficult in patients with low rectal tumors, narrow pelvic anatomy, male sex or
      high body mass index . Difficult visualization of the pelvic anatomy along with the
      limitation of rigid laparoscopic instruments may affect the quality of oncological outcomes
      and increase the risks of injuries during surgery. A down to up approach via transanal total
      mesorectal excision (TaTME) technique may overcome these problems
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical trial will be conducted at general surgery department of Assiut University
      Hospital .
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative complication</measure>
    <time_frame>1 day</time_frame>
    <description>complication occured intraoperatively or on the first day of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>resection margin</measure>
    <time_frame>1 years</time_frame>
    <description>circumferential resection margin microscopic examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>1 years</time_frame>
    <description>rate of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morbidity rate</measure>
    <time_frame>1 year</time_frame>
    <description>rate of postoperative morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrance rate</measure>
    <time_frame>2 years</time_frame>
    <description>rate of local recurance( by CT scan )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anorectal function outcomes</measure>
    <time_frame>2 years</time_frame>
    <description>manometric assessment of anorectal function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual functional outcomes</measure>
    <time_frame>2 years</time_frame>
    <description>sexual function with IIEF(International Index of Erectile Function) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mesorectal completeness</measure>
    <time_frame>1 year</time_frame>
    <description>The quality of the mesorectum or TME specimen(pathological examination)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>transanal TME</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic Assisted Transanal Total Mesorectal Excision</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Assisted Transanal Total Mesorectal Excision</intervention_name>
    <description>Abdominal approach with laparoscopic mobilization of the left colon
Laparoscopic isolation and transection of inferior mesenteric vessels .
Transabdominal dissection of the upper rectum and mesorectam.
Insertion of transanal platform and the creation of pneumorectum.
Occlusion of rectum 2 cm distal to the rectal lesion via purse string.
Transanal dissection of lower and mid mesorectam
The specimen will be extracted transanally</description>
    <arm_group_label>transanal TME</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • rectal cancer histologically proven through biopsy

               -  tumours located at least 3 cm from anorectal ring;

               -  local spread restricted to the rectal wall

               -  adequate preoperative sphincter function and continence;

               -  absence of distant metastases.

               -  Suitable for elective surgical resection

        Exclusion Criteria:

          -  • T4 tumours not responding to neoadjuvant chemo- radiotherapy

               -  Patients under 18 years of age

               -  Pregnancy

               -  Previous rectal surgery (except local excision, endoscopic mucosal resection
                  (EMR) or polypectomy)

               -  Patients with acute intestinal obstruction

               -  Multiple colorectal tumours

               -  Familial Adenomatosis Polyposis Coli (FAP), Hereditary Non-Polyposis Colorectal
                  Cancer (HNPCC), Crohn's disease or ulcerative colitis

               -  Planned synchronous abdominal organ resections

               -  Preoperative evidence for distant metastases through imaging of the thorax and
                  abdomen

               -  Absolute contraindications to general anaesthesia,

               -  presence of fecal incontinence,

               -  undifferentiated tumors .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>samir a ali, phd</last_name>
    <role>Study Director</role>
    <affiliation>assuit university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mohamed abulfetouh, MD</last_name>
    <phone>0201098904323</phone>
    <email>m.abulfetouh@aun.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assuit Universty Hospital</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>samir a ali, PHD</last_name>
      <phone>02088403255</phone>
      <email>samir.ali@med.au.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Kang L, Chen WH, Luo SL, Luo YX, Liu ZH, Huang MJ, Wang JP. Transanal total mesorectal excision for rectal cancer: a preliminary report. Surg Endosc. 2016 Jun;30(6):2552-62. doi: 10.1007/s00464-015-4521-2. Epub 2015 Aug 27.</citation>
    <PMID>26310534</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2017</study_first_submitted>
  <study_first_submitted_qc>May 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>May 28, 2017</last_update_submitted>
  <last_update_submitted_qc>May 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>mohamed abulfetouh</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

